Article Information
History
- November 18, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ruthly François1,
- Melchior Mwandagalirwa Kashamuka2,
- Kristin Banek1,
- Joseph A. Bala2,
- Marthe Nkalani2,
- Georges Kihuma2,
- Joseph Atibu2,
- Georges E. Mahilu2,
- Kyaw L. Thwai1,
- Ashenafi Assefa1,
- Jeffrey A. Bailey3,
- Rhoel R. Dinglasan4,
- Jonathan J. Juliano1,
- Antoinette Tshefu2,# and
- Jonathan B. Parr1,#,*
- 1University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
- 2Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo
- 3Brown University, Providence, RI, United States
- 4University of Florida, Gainesville, FL, United States
- ↵*Corresponding: Jonathan B. Parr, MD, MPH; 111 Mason Farm Rd, CB#7036, Chapel Hill, NC 27599; jonathan_parr{at}med.unc.edu; 1-919-445-1132.
Posted November 18, 2022.
Plasmodium falciparum with pfhrp2/3 deletion not detected in a 2018-2021 malaria longitudinal cohort study in Kinshasa Province, Democratic Republic of the Congo
